Blog

Keep up to date with the latest news from Instem.

Selection
  • All
  • Study Management (50)
  • Sensible SEND (90)
  • SEND (101)
  • Regulatory Submission (109)
  • Quality System Management (12)
  • Provantis (8)
  • Pristima (2)
  • Press Releases (30)
  • NOTOCORD-hem (5)
  • Meet the Experts (3)
  • Matrix Gemini (16)
  • Leadscope (6)
  • Lab Execution (16)
  • In Silico Insider (21)
  • In Silico & Data Insights (19)
  • Compliance Builder (4)
  • Company News (19)
  • Clinical (25)
  • Climb (6)
  • BioRails (1)
AcademicBiotechCROPharmaceuticalPre-ClinicalSafety PharmacologySENDSEND Advantage ServicesSensible SENDStudy Management

Webinar Recap: When SEND Quality Matters Most

Instem Team

Our recent webinar, “When SEND Quality Matters Most”, explored the recent FDA communications regarding data quality, why regulatory expectations are shifting, where common issues arise, and how organizations can strengthen confidence before filing SEND datasets...

Compliance BuilderPre-ClinicalQuality System ManagementRegulatoryRegulatory Submission

Webinar Recap: Closing Compliance Gaps with Compliance Builder

Instem Team

Comprehensive electronic recordkeeping is a cornerstone of all laboratory functions in regulated industries, but establishing and maintaining 21 CFR Part 11 compliance is challenging when processes are fragmented across multiple instruments and systems.

CRODiscoveryIn Silico & Data InsightsIn Silico InsiderLeadscopeLeadscope Model ApplierPharmaceuticalPre-ClinicalPredictive ToxicologyToxicology

Advancing Risk-Based E&L Safety Assessment: The Role of ICH Q3E and Leadscope

Jignyasa Bal

As ICH Q3E advances a risk-based paradigm for E&L safety, the question is shifting from whether to assess risk toward how to do it consistently across a vast and diverse chemical space. Leadscope enables structure...

AgencyArtificial Intelligence and Machine LearningClimbCompany NewsCROPharmaceuticalPre-ClinicalProvantisRegulatory ComplianceRegulatory SubmissionsSENDSEND Advantage ServicesStudy ManagementSubmit

Instem Interact 2026 – A Resounding Success

Instem Team

Turning Insight into Innovation in Preclinical R&D

Stay up to Date

Get expert tips, industry news, and fresh content delivered to your inbox.